Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Shekhar

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Molecular Pharmaceutics|July 24, 2008
Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapyAyman Khdair, Brigitte Gerard, Hitesh Handa, et al.
Cancer Research|March 15, 2008
Rad6B is a positive regulator of beta-catenin stabilizationMalathy P V Shekhar, Brigitte Gerard, Robert J Pauley, et al.
Oncotarget|November 17, 2018
Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivityKelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
Oncotarget|March 25, 2014
Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivityKelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
Medical Oncology (Northwood, London, England)|May 26, 2009
Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy responseMalathy P V Shekhar, Laura A Biernat, Nat Pernick, et al.
International Journal of Oncology|October 17, 1998
Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancerP V Shekhar, M L Chen, J Werdell, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 16, 2009
Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistanceAyman Khdair, Di Chen, Yogesh Patil, et al.
Translational Oncology|May 17, 2014
Rad6 is a Potential Early Marker of Melanoma DevelopmentKarli Rosner, Shreelekha Adsule, Brittany Haynes, et al.
The American Journal of Pathology|November 12, 2020
RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin SignalingAshapurna Sarma, Ambikai Gajan, Seongho Kim, et al.
Molecular Pharmaceutics|August 21, 2007
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug effluxMahesh D Chavanpatil, Ayman Khdair, Brigitte Gerard, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Molecular Pharmaceutics|July 24, 2008
Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapyAyman Khdair, Brigitte Gerard, Hitesh Handa, et al.
Cancer Research|March 15, 2008
Rad6B is a positive regulator of beta-catenin stabilizationMalathy P V Shekhar, Brigitte Gerard, Robert J Pauley, et al.
Oncotarget|November 17, 2018
Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivityKelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
Oncotarget|March 25, 2014
Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivityKelly K Haagenson, Jessica Wei Zhang, Zhengfan Xu, et al.
Medical Oncology (Northwood, London, England)|May 26, 2009
Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy responseMalathy P V Shekhar, Laura A Biernat, Nat Pernick, et al.
International Journal of Oncology|October 17, 1998
Transcriptional activation of functional endogenous estrogen receptor gene expression in MCF10AT cells: a model for early breast cancerP V Shekhar, M L Chen, J Werdell, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 16, 2009
Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistanceAyman Khdair, Di Chen, Yogesh Patil, et al.
Translational Oncology|May 17, 2014
Rad6 is a Potential Early Marker of Melanoma DevelopmentKarli Rosner, Shreelekha Adsule, Brittany Haynes, et al.
The American Journal of Pathology|November 12, 2020
RAD6B Loss Disrupts Expression of Melanoma Phenotype in Part by Inhibiting WNT/β-Catenin SignalingAshapurna Sarma, Ambikai Gajan, Seongho Kim, et al.
Molecular Pharmaceutics|August 21, 2007
Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug effluxMahesh D Chavanpatil, Ayman Khdair, Brigitte Gerard, et al.
Pageof 4